source Post navigation Evaluating Pro- and Anti-inflammatory Biomarkers for Predicting Type 2 Diabetes Mellitus in the Geriatric Population and Correlation With Clinical and Biochemical Parameters – Cureus Empagliflozin, Dapagliflozin Comparably Reduce AKI, CKD Risks in Diabetes Population – Renal and Urology News